HPV Vaccine at 20: Proven Cancer Prevention Tool Faces Uptake Challenges
By
Cristina Ferrario
Summary
The article marks the 20th anniversary of the FDA's approval of the first HPV vaccine in 2006, highlighting its evolution from a quadrivalent vaccine targeting cancer-causing HPV types 16/18 and wart-causing types 6/11 to newer formulations and schedules. It discusses the vaccine's proven effectiveness as a cancer prevention tool while emphasizing that improving uptake remains a critical public health challenge to fully realize its long-term benefits.
Source
Twitter / XHPV Vaccine at 20: Proven Cancer Prevention Tool Faces Uptake Challengesmdsc.peKey quotes
· 3 pulledTwenty years ago, a major milestone in cancer prevention was reached when the US.
Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.
The quadrivalent vaccine protected against HPV types 16 and 18, which are responsible for most HPV-related cancers, as well as HPV types 6 and 11, which cause genital warts but have low oncogenic potential.
You might also wanna read
HPV vaccine eliminates cervical cancer cases in vaccinated Scottish women, landmark studies show
Landmark population-based studies from Scotland and the Netherlands provide compelling real-world evidence that HPV vaccines are highly effe
gavi.org·14d ago
HPV vaccine nearly eliminates cervical cancer deaths in vaccinated young women, landmark study finds
A landmark study reveals that girls vaccinated against HPV at age 12-13 have close to zero risk of dying from cervical cancer before age 30.
bbc.com·1d agoHPV vaccine nearly eliminates cervical cancer deaths in vaccinated young women, landmark study finds
A landmark study reveals that girls vaccinated against HPV at age 12-13 have close to zero risk of dying from cervical cancer before age 30.
bbc.com·1d ago
Long-term HPV vaccine effectiveness study shows stable protection against targeted virus types in Danish women vaccinated as girls
This study examines the long-term effectiveness of HPV vaccination in Danish women who received the 4-valent HPV vaccine as girls in 2008. T
eurosurveillance.org·5mo ago
Denmark Eliminates Leading Cancer-Causing HPV Strains Following 2008 Vaccine Rollout
Denmark has successfully eliminated infections from the two most dangerous cancer-causing HPV strains (types 16 and 18) following the introd
gavi.org·9mo ago
How the HPV Vaccine Prevents Cancer: The Blurring Line Between Infectious and Chronic Disease
The article discusses the blurring boundary between infectious and chronic diseases, using the HPV vaccine as a key example. It highlights h
jenndowd.substack.com·22d ago
Personalized mRNA vaccine from Moderna and Merck halves melanoma recurrence risk over five years
A personalized mRNA vaccine developed by Moderna and Merck has shown in new clinical trial results that it halves the risk of melanoma retur
nbcnews.com·19d agoComments
Sign in to join the conversation.
No comments yet. Be the first.